Celano Michael 4
4 · Larimar Therapeutics, Inc. · Filed Jan 27, 2026
Research Summary
AI-generated summary of this filing
Larimar (LRMR) CFO Michael Celano Receives Stock Awards
What Happened Michael Celano, Chief Financial Officer of Larimar Therapeutics (LRMR), received equity awards on January 26, 2026: 37,604 restricted stock units (RSUs) and 225,622 additional derivative awards. Both grants were reported at $0.00 per share (no cash paid at grant), so the reported acquisition value is $0.
Key Details
- Transaction date: 2026-01-26; Form filed: 2026-01-27.
- Awards: 37,604 RSUs (each RSU represents a contingent right to one share on settlement) and 225,622 derivative awards reported as acquired at $0.00.
- Vesting/conditions: The larger derivative award is subject to a vesting schedule — 25% vests on Jan 26, 2027, then the remaining 75% vests in equal monthly installments over the next 36 months, contingent on continued service.
- Post-transaction holdings: The filing excerpt provided does not state total shares owned after these grants.
- Filing timeliness: Filed the day after the transaction date; no late filing indicated.
Context These were equity compensation grants, not open‑market purchases or sales. RSUs and time‑vesting derivative awards are common retention/compensation tools; they do not represent immediate cash proceeds or share sales and generally convert to shares only as they vest and any settlement conditions are met.
Insider Transaction Report
- Award
Common Stock
[F1]2026-01-26+37,604→ 215,785 total - Award
Stock Option (Right to Buy)
[F2]2026-01-26+225,622→ 225,622 totalExercise: $3.60Exp: 2036-01-26→ Common Stock (225,622 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.